We unite AI and cutting-edge science to discover and develop new medicines for complex diseases.
WHAT WE DO →The Benevolent Platform™ enables scientists to navigate an ever-expanding data landscape to map complex multifactorial diseases in unprecedented detail. Our AI tools generate valuable insights from this data, empowering scientists to formulate new hypotheses and rapidly discover high-quality drug targets based on a better understanding of disease. And this better understanding of disease leads to more effective drugs for patients in need — because it matters.
We have a proven track record of success. The Benevolent Platform™ has generated every drug programme in our pipeline, which spans from target discovery to the clinic, mixing potentially best-in-class and first-in-class drug candidates.
DRUG PROGRAMMES →.png)
We partner with pharmaceutical and biotech companies to discover novel treatments using the Benevolent Platform™, which can uniquely find targets for any disease and drug modality.
WORK WITH US →
BenevolentAI embodies a new type of culture based on genuine collaboration between scientists and technologists who co-create the Benevolent Platform™ and work together to redefine how drugs are discovered and developed. If you are curious and collaborative and want to help shape a future of new discoveries, we would love to hear from you.
